These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15770819)

  • 1. [Auto-immune liver diseases and their treatment].
    Hess J; Thorens J; Pache I; Troillet FX; Moradpour D; Gonvers JJ
    Rev Med Suisse; 2005 Jan; 1(3):242, 245-7. PubMed ID: 15770819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune cholangitis: case report.
    Marinho R; Graça H; Ramalho F; Costa A; Batista A; de Moura MC
    Hepatogastroenterology; 1999; 46(27):1949-52. PubMed ID: 10430375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Tunis Med; 2003 Jul; 81(7):499-504. PubMed ID: 14534962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
    Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
    Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathologic diagnosis of autoimmune liver disease].
    Pan MH; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):772-6. PubMed ID: 18307886
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.
    Ozaslan E; Efe C; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Muratori L; Ustündag Y; Bresson-Hadni S; Thiéfin G; Schiano TD; Wahlin S; Muratori P
    Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune-mediated liver diseases].
    Pár A
    Orv Hetil; 2007 Apr; 148 Suppl 1():35-8. PubMed ID: 17430792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary biliary cirrhosis and the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
    Wendum D
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S54-5. PubMed ID: 18984300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Overlap syndrome autoimmune hepatitis and primary biliary cirrhosis associated with antiphospholipid syndrome].
    Targońska-Stepniak B; Majdan M; Suszek D; Laskowska K
    Pol Merkur Lekarski; 2006 Nov; 21(125):480-3. PubMed ID: 17345845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy: autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis].
    Strassburg CP
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S202-4. PubMed ID: 16435709
    [No Abstract]   [Full Text] [Related]  

  • 17. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
    Kayacetin E; Köklü S; Temuçin T
    Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis.
    Czaja AJ; Muratori P; Muratori L; Carpenter HA; Bianchi FB
    Liver Int; 2004 Aug; 24(4):322-9. PubMed ID: 15287855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
    Stiehl A
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.